Concepedia

Author

Antonio Cubillo

Hospital Universitario HM SanchinarroORCID

Also Known As

A Cubillo, A. Cubillo, Alfonso del Cuvillo, Antonio Cubillo, Cubillo, A., Cubillo, Antonio, Esther Molina-Montes

184

Publications

3K

Citations

24

H-Index

39

Concepts

All Affiliations

Hospital Universitario HM SanchinarroVall d'Hebron Hospital UniversitariUniversidad San Pablo CEUCentro Oncológico de GaliciaHospital General Universitario Gregorio Marañón
AC

About

Antonio Cubillo is an author at Hospital Universitario HM Sanchinarro specializing in oncology, medicine, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

15

1.6K

2

Health Sciences

6

6

159

3

Engineering

1

1

58

4

Biomedical Engineering

1

1

58

5

Hepatology

1

1

58

Antonio Cubillo

×

35

Publications

2.7K

Citations

23

H-Index

YearCitations

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Andrea Wang‐Gillam, Chung‐Pin Li, G. Bodoky,

The Lancet

2015

1.2K

Stromal disrupting effects of nab-paclitaxel in pancreatic cancer

Rafael Álvarez, Mónica Musteanu, Elena García-García,

British Journal of Cancer

2013

289

Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses

Clara Montagut, Guillem Argilés, Fortunato Ciardiello,

JAMA Oncology

2018

142

Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer

Eric Van Cutsem, Manuel Hidalgo, Jean‐Luc Canon,

International Journal of Cancer

2018

100

A comparative study of neoadjuvant treatment with gemcitabine plus nab-paclitaxel versus surgery first for pancreatic adenocarcinoma

Benedetto Ielpo, Riccardo Caruso, Hipólito Durán,

Surgical Oncology

2017

74

Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab

Rodrigo A. Toledo, Antonio Cubillo, Estela Vega,

Oncotarget

2016

59

Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial

Philippe Merle, Jean‐Frédéric Blanc, Jean–Marc Phelip,

˜The œLancet. Gastroenterology & hepatology

2019

58

Complete pathological responses in locally advanced rectal cancer after preoperative IMRT and integrated-boost chemoradiation

Ovidio Hernando-Requejo, Mercedes López, Antonio Cubillo,

Strahlentherapie und Onkologie

2014

54

Population Pharmacokinetics of Liposomal Irinotecan in Patients With Cancer

B. Adiwijaya, J. Kim, István Láng,

Clinical Pharmacology & Therapeutics

2017

54

Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours

Éric Raymond, Matthew H. Kulke, Shukui Qin,

Neuroendocrinology

2018

54

Page 1